Several Central Mass. organizations were among the 28 community hospitals to receive awards totaling $60 million from the Massachusetts Health Policy Commission (HPC), it announced on Wednesday.
A global shortage of software developers, on top of shortages of nurses and midwives in England, is creating challenges for the health technology industry, the head of a mobile software company headquartered in Belfast said Tuesday.
Harrington HealthCare System (HHS) has begun a renovation and expansion of its emergency department at its Webster campus that it expects will be finished in December.
Boston Scientific of Marlborough has launched a trial of a coronary stent system to get more information about the product's use in underserved populations, including women and people of color, the company announced Monday.
A medical facility near Logan International Airport does not have access to the preferred protective suits for medical workers to handle Ebola cases, and even the head of one of the state's largest hospitals told a legislative committee the current level of training is insufficient.
Worcester-based drug and alcohol treatment center operator AdCare has completed its acquisition of SSTAR of North Kingstown, R.I., the company announced.
Massachusetts has not designated any particular medical facility for Ebola cases within Bay State borders but officials say all Massachusetts hospitals are ready for suspect cases.
The Marist Fathers of Boston have struggled to sell a former religious retreat center on Framingham's Pleasant Street since it was listed for sale in the spring of 2012, and after almost a year-and-a-half of working with a Waltham-based health care company, the order of priests is back at square one.
Gregory Katz, an attorney with the Boston firm Ropes & Grey, who represents the Marist Fathers, said opposition from neighbors who did not want Walden Behavioral Care to construct and open an inpatient psychiatric treatment center in the residential area forced his client to abandon a purchase-and-sale agreement with Walden.
An international group of scientists led by Dr. Gang Han of UMass Medical School (UMMS) has combined a new type of nanoparticle with an FDA-approved photodynamic therapy to effectively kill deep-set cancer cells with minimal damage to surrounding tissue and fewer side effects than chemotherapy.